TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ABEO

Abeona Therapeutics Inc

Healthcare · Biotechnology

5.70$ +1.8% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

Abeona Therapeutics Inc (ABEO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -76 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ABEO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-1.6 -10 -13 -23 -39 -63 -35 -66 -43 -37 -56 -76
0.0 0.6 0.8 0.7 2.4 8.7 5.6 4.5 4.6 3.2 2.9 3.6
1.3 4.4 4.8 5.9 8.9 8.2 8.2 8.9 3.1 4.8 6.6 11
25 4.8 4.8 4.5 7.6 7.3 42 33
0.4 -6.1 -0.2 -2.1 7.0 -3.6 1.6 -18 -5.9 -1.8 -4.4 -5.4
0.3 0.3 0.5 0.9 19 6.5 1.3 4.2 0.1 0.3 2.4 8.0
3.4 3.4 -0.5 -0.9 -85 60 -84 66 -24 0.2 -39 105
11,579 0.0 0.0 0.0
12 12 43 92 5.5 18 0.2 0.0 -26 -0.2
0.4 -0.4 1.8 1.8 1.8 1.8 0.0 0.0 20 0.0
13 36 43 92 5.5 114 1.9 25 43 37 104 26
11 29 29 69 -119 111 -117 25 -24 0.3 8.9 55
-1.6 -11 -14 -24 -59 -69 -36 -70 -44 -37 -58 -84

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?